Discontinued Drugs
The Drugs.com Discontinued Drug Shortages List is a searchable database that provides up-to-date information related to drug discontinuations, sorted by generic name and latest revision date. The reason for the discontinuation and estimated resupply date, if available, is listed for each individual agent.
Current | Resolved | Discontinued
| Generic Name | Revision Date |
|---|---|
| 5% Lidocaine and 7.5% Dextrose Injection | June 13, 2022 |
| Abciximab Injection | April 29, 2019 |
| Albuterol Sulfate Extended-Release Tablets | June 30, 2021 |
| Alfentanil Injection | February 22, 2023 |
| Alprostadil Urethral Suppositories | August 29, 2024 |
| Amifostine Injection | April 24, 2025 |
| Ammonium Chloride Injection | January 31, 2017 |
| Ammonium Molybdate Injection | September 26, 2018 |
| Amobarbital Sodium Injection | September 22, 2024 |
| Bacitracin for Injection | March 4, 2020 |
Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah, provided by ASHP as its exclusive authorized distributor, and used with permission. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.